PHYLLIS JACKSON: Open Payments
NPI 1043649627 · GLEN MILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 24 payments from 16 companies in 2025. Trend: 2023 $740 · 2024 $365 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $113 |
| Biogen, Inc. | 2 | $49 |
| Boston Scientific Corporation | 1 | $40 |
| Eisai Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $23 |
| Insulet Corporation | 1 | $22 |
| UCB, Inc. | 1 | $21 |
| TG Therapeutics, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
Products named: UBRELVY, VUMERITY, General - DBS, Leqembi, AUSTEDO XR, AMYVID, Omnipod, Rystiggo.
Industry payments across PA — which companies pay providers there.
